Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,423 | 866 | 96.3% |
| Honoraria | $440.00 | 2 | 3.2% |
| Education | $74.49 | 6 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,849 | 132 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,093 | 72 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,089 | 103 | $0 (2022) |
| IRONSHORE PHARMACEUTICALS INC. | $956.37 | 58 | $0 (2024) |
| Neuronetics, Inc. | $884.84 | 24 | $0 (2023) |
| ABBVIE INC. | $741.53 | 39 | $0 (2024) |
| Alkermes, Inc. | $697.22 | 33 | $0 (2024) |
| Neos Therapeutics, LP | $656.93 | 38 | $0 (2023) |
| Axsome Therapeutics, Inc. | $647.91 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $636.51 | 61 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,785 | 79 | Axsome Therapeutics, Inc. ($348.30) |
| 2023 | $1,826 | 82 | Supernus Pharmaceuticals, Inc. ($370.28) |
| 2022 | $1,766 | 105 | Supernus Pharmaceuticals, Inc. ($390.88) |
| 2021 | $2,055 | 133 | Supernus Pharmaceuticals, Inc. ($298.30) |
| 2020 | $1,408 | 98 | Otsuka America Pharmaceutical, Inc. ($426.64) |
| 2019 | $1,747 | 147 | Otsuka America Pharmaceutical, Inc. ($321.51) |
| 2018 | $1,999 | 137 | Neuronetics, Inc. ($539.47) |
| 2017 | $1,352 | 93 | Neuronetics, Inc. ($278.97) |
All Payment Transactions
874 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: CNS | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $82.14 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/12/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/12/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $17.87 | General |
| 11/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $96.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.72 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $45.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 126 | 514 | $78,450 | $34,857 |
| 2022 | 4 | 130 | 533 | $74,150 | $35,962 |
| 2021 | 4 | 139 | 548 | $77,800 | $36,572 |
| 2020 | 4 | 143 | 577 | $77,470 | $35,030 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 22 | 253 | $48,070 | $19,220 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 101 | $16,160 | $7,864 | 48.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 36 | 113 | $9,040 | $5,205 | 57.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 31 | $3,100 | $1,875 | 60.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 11 | 16 | $2,080 | $692.64 | 33.3% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 17 | 169 | $32,110 | $12,837 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 143 | $22,880 | $11,823 | 51.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 36 | 147 | $11,760 | $6,943 | 59.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 74 | $7,400 | $4,359 | 58.9% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 14 | 194 | $36,860 | $15,754 | 42.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 140 | $22,400 | $11,095 | 49.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 40 | 143 | $11,440 | $6,015 | 52.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 71 | $7,100 | $3,710 | 52.2% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 18 | 191 | $36,290 | $14,956 | 41.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 41 | 156 | $12,480 | $7,391 | 59.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 95 | $15,200 | $6,440 | 42.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 135 | $13,500 | $6,242 | 46.2% |
About Dr. Vishwas Mashalkar, M.D
Dr. Vishwas Mashalkar, M.D is a Psychiatry healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972628451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vishwas Mashalkar, M.D has received a total of $13,938 in payments from pharmaceutical and medical device companies, with $1,785 received in 2024. These payments were reported across 874 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($13,423).
As a Medicare-enrolled provider, Mashalkar has provided services to 538 Medicare beneficiaries, totaling 2,172 services with total Medicare billing of $142,420. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Toledo, OH
- Active Since 03/21/2007
- Last Updated 07/08/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1972628451
Products in Payments
- VRAYLAR (Drug) $1,187
- REXULTI (Drug) $1,104
- LATUDA (Drug) $1,089
- QELBREE (Drug) $1,013
- JORNAY PM (Drug) $817.26
- Auvelity (Drug) $647.91
- Adzenys XR-ODT (Drug) $612.76
- NEUROSTAR TMS THERAPY (Device) $574.64
- ABILIFY MAINTENA (Drug) $520.30
- TRINTELLIX (Drug) $498.07
- VYVANSE (Drug) $432.47
- SPRAVATO (Drug) $388.46
- ABILIFY MYCITE (Drug) $338.67
- CAPLYTA (Drug) $301.84
- NeuroStar TMS Therapy (Device) $278.97
- LYBALVI (Drug) $256.69
- Azstarys (Drug) $252.03
- Dyanavel XR (Drug) $215.95
- BRINTELLIX (Drug) $213.46
- Trintellix (Drug) $188.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Toledo
Mr. David Jahn, Md, MD
Psychiatry — Payments: $519,775
Dr. Irfan Ahmed, Md, MD
Psychiatry — Payments: $172,792
Laurie Veltri, Pa-C, PA-C
Psychiatry — Payments: $17,595
Khawaja Shahzad, M.d, M.D
Psychiatry — Payments: $8,766
Robert Smith, Md, MD
Psychiatry — Payments: $7,500
Dr. Tim Valko, Md, MD
Psychiatry — Payments: $6,646